Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06340360
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-03-25
Brief Title:
A Phase 2b Study to Evaluate Rezpegaldesleukin Rezpeg in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients Rezolve AA
Sponsor:
Nektar Therapeutics
Organization:
Nektar Therapeutics
Organization Data
Organization:
Nektar Therapeutics
Class:
INDUSTRY
Study ID:
23-358-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nektar Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None